Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.
about
TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Gemtuzumab ozogamicin in acute myeloid leukemia.Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia.Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone.Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.
P2860
Q38138901-A2BC4B12-1A01-4896-BEDC-28BABA441594Q38195065-5C227ABE-64B5-4819-886D-6EF86FB78BC5Q38700209-30A12511-2D36-4D96-AEFF-883A915FAF0CQ38728718-F13FB341-FD72-494B-A8FA-216236BF7B58Q42720957-CD3C1AAB-6A45-4856-8250-0563C94BB793Q44073282-246813F1-BB78-43EF-9A8C-E27326F39720Q52846906-6A261C1D-9A7D-45AF-82F6-CA2E1CC7758C
P2860
Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.
@en
type
label
Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.
@en
prefLabel
Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.
@en
P2860
P1476
Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.
@en
P2093
Akihiro Takeshita
P2860
P2888
P304
P356
10.1007/S12185-013-1365-1
P577
2013-05-26T00:00:00Z
P5875
P6179
1019913697